期刊文献+

类黄酮CDKs抑制剂的合成及其抗肿瘤活性的研究(Ⅰ) 被引量:4

The synthesis and anticancer activity study of flavonoids as CDKs inhibitors(Ⅰ)
原文传递
导出
摘要 目的寻找活性更好的类黄酮细胞周期蛋白依赖性激酶(CDKs)抑制剂。方法利用查尔酮路线合成了9个类黄酮。结果目标化合物的结构经IR、1HNMR、质谱确证,并测定了化合物对CDK1的抑制活性以及对HCT116的体外抗肿瘤活性。结论有5个化合物对CDKs的抑制活性高于对照Flavopiridol,所有化合物对HCT116均显示较强的抑制活性。 OBJECTIVE To search flavonoids with higher cyclin-dependent kinase(CDKs) inhibition.METHODS Chalcone route was applied to the synthesis of 9 chalcones.RESULTS The structure of target compounds was confirmed by IR,1HNMR and MS.CDKs inhibition as well as cytotoxicity activity against HCT116 of above compounds were determined.CONCLUSION The result indicated that five compounds exhibited higher CDKs inhibition than flavopiridol,all compounds demonstrated higher cytotoxicity activity against HCT116.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第1期20-22,共3页 West China Journal of Pharmaceutical Sciences
基金 国家科技部863课题(No.2007AA02Z314)
关键词 查尔酮 类黄酮 细胞同期蛋白依赖性激酶 CDKs抑制活性 抗肿瘤活性 Chalcones Flavonoids Cyclin-dependent kinase CDKs inhibition Anticancer activity
  • 相关文献

参考文献6

  • 1Follette PJ, O' Farrell PH. CDKs and the Drosophila cell cycle[ J ]. Curr Opin Genet Dev, 1997,7 ( 1 ) : 17 - 22.
  • 2Malumbres M,Barbacid M. To cycle or not to cycle:a critical de- cision in cancer[ J ]. Nat Rev Can,2001, 1:222 -231.
  • 3Ren W ,Qiao Z,Wang H,et al. Flavonoids: promising anticancer agents[J]. Med Res Rev,2003,23 (4) :519 -34.
  • 4Ducki S. The development of chalcones as promising anticancer agents[ J]. Drugs,2007,10 ( 1 ) :42 - 46.
  • 5Kattige S, Naik R, Alakdawall AD, et al. 4H - benzopyran - 4 - one compounds which have anti - inflammatory or immunodulat- ing action[ P]. US,4,900,727,1990 -2 -13.
  • 6刘滔,胡永洲.2'-羟基查耳酮的Mannich反应及其产物的生物活性[J].有机化学,2006,26(7):983-987. 被引量:25

二级参考文献11

  • 1关丽萍,尹秀梅,全红梅,全哲山.羟基查尔酮类衍生物的合成[J].有机化学,2004,24(10):1274-1277. 被引量:40
  • 2Middleton,E.J.; Kandaswami,C.; Theoharides,T.C.Pharmacol.Rev.2000,52,673.
  • 3Galati,G.; Teng,S.; Moridani,M.Y.; Chan,T.S.; O'Brien,P.J.Drug Metab.Drug Interact.2000,17,311.
  • 4Yang,C.S.; Landau,J.M.; Huang,M.T.; Newmark,H.L.Annu.Rev.Nutr.2001,21,381.
  • 5Murthi,K.K.; Dubay,M.; McClure,C.; Brizuela,L.; Boisclair,M.D.; Worland,P.J.; Mansuri,M.M.; Pal,K.Bioorg.Med.Chem.Lett.2000,10,1037.
  • 6Huwe,A.; Mazitschek,R.; Giannis,A.Angew.Chem.,Int.Ed.2003,42,2122.
  • 7Pouget,C.; Lauthier,F.; Simon,A.; Fagnere,C.; Basly,J.-P.; Delage,C.; Chulia,A.-J.Bioorg.Med.Chem.Lett.2001,11,3095.
  • 8Gulati,K.C.; Seth,S.R.; Venkataraman,K.Org.Synth.Coll.1943,2,522.
  • 9Juntend,K.Y.T.; Junte,T.S.T.EP 292576,1988[Chem.Abstr.1988,110,23539].
  • 10Dhar,D.N.J.Org.Chem.1960,25,1247.

共引文献24

同被引文献95

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部